Enalapril in subantihypertensive dosage attenuates kidney proliferation and functional recovery in normotensive ablation nephropathy of the rat

Physiological Research

Volumn 48, Issue 6, 1999, Pages 429-435

  Krivosikova Z ^a   Sebekova K ^a   Spustova V ^a   Lajdova I ^a   Dzurik R ^a  

^a INST OF PREV AND CLINICAL MEDICINE   (Slovakia)

Author keywords

Ablation nephropathy; Collagen; Creatinine clearance; DNA; Enalapril; Proteins; Proteinuria; Remnant kidney model

Indexed keywords

CREATININE; DNA; ENALAPRIL; M PROTEIN; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE; CELL PROLIFERATION; CONTROLLED STUDY; CREATININE CLEARANCE; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY MASS; NEPHRECTOMY; NONHUMAN; RAT;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD PRESSURE; BLOOD UREA NITROGEN; CELL DIVISION; COLLAGEN; CREATININE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENALAPRIL; HYPERPLASIA; HYPERTENSION, RENAL; HYPERTROPHY; KIDNEY; MALE; NEPHRECTOMY; ORGAN SIZE; PROTEINURIA; RATS; RATS, WISTAR;

EID: 0033391106     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. ANDERSON S, MEYER TW, RENNKE HG, BRENNER BM: Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 76: 612-619, 1985.
2. DUBEY RK, ROY A, OVERBECK HW: Culture of renal arteriolar smooth muscle cells. Mitogenic responses to angiotensin II. Circ Res 71: 1143-1152, 1992.
3. DZAU VJ, RE R: Tissue angiotensin system in cardiovascular medicine. A paradigm shift. Circulation 89: 493-498, 1994.
4. HARRIS DA: Fluorometric assay for DNA with Hoechst 33258. In: Spectrophotometry and Spectrofluorometry. DA FARRIS, CE BASHFORD (eds), IRE Press, Washington, 1987, pp 64-65.
5. HARRIS RC, MARTINEZ-MALDONADO M: Angiotensin II-mediated renal injury. Miner Electrolyte Metab 21: 328-335, 1995.
6. JUNAID A, HOSTETTER TH, ROSENBERG ME: Interaction of angiotensin II and TGF-α1 in the rat remnant kidney. J Am Soc Nephrol 8: 1732-1738, 1997.
7. KAKINUMA Y, KAWAMURA T, BILLS T, YOSHIOKA T, ICHIKAWA I, FOGO A: Blood pressure-independent effect of angiotensin inhibition on vascular lesions of chronic renal failure. Kidney Int 42: 46-55, 1992.
8. LAFAYETTE RA, MAYER G, PARK SK, MEYER TW: Angiotensin receptor blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest 90: 766-771, 1992.
9. MAYER G, LAFAYETTE RA, OLIVER J, DEEN WM, MYERS BD, MEYER TW: Effects of angiotensin II receptor blockade on remnant glomerular permselectivity. Kidney Int 43: 346-353, 1993.
10. NEURIGNER JR, BRENNER BM: Hemodynamic theory of progressive renal disease: a 10-year update in brief review. Am J Kidney Dis 22: 98-104, 1993.
11. REDDY GK, ENWEMEKA CS: A simplified method for the analysis of hydroxyproline in biological tissues. Clin Biochem 29: 225-229, 1996.
12. REMUZZI A, PUNTORIERI S, BATTAGLIA C, BERTANI T, REMUZZI G: Angiotensin-converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat. J Clin Invest 85: 541-549, 1990.
13. ROSENBERG ME, SMITH LJ, CORREA-ROTTER R, HOSTETTER TH: The paradox of the renin-angiotensin system in chronic renal disease. Kidney Int 45: 403-410, 1994.
14. SMITH PK, KROHN RJ, HREMANSON GT, MALLIA AK, GARTNER FH, PROVENZANO MD, FUJIMOTO EK, GOEKE NM, OESON BJ, KLENK DC: Measurement of protein using bicinchoninic acid. Anal Biochem 150: 76-85, 1985.
15. SPIRO RG: Studies on the renal glomerular basement membrane. Preparation and chemical composition. J Biol Chem 242: 1915-1919, 1967.
16. WILLIAMS GR, HARRISON TR, GROLLMAN A: A simple method for determining the systolic blood pressure of unanesthesized rats. J Clin Invest 18: 373-383, 1939.
17. WOLF G, NEILSON EG: Angiotensin II as a renal growth factor. J Am Soc Nephrol 3: 1531-1540, 1993.
18. ZOJA C, BENIGNI A, LIVIO M, BERGAMELLI A, ORISIO S, ABBATE M, BERTANI T, REMUZZI G: Selective inhibition of platelet thromboxane generation with low-dose aspirin does not protect rats with reduced renal mass from the development of progressive disease. Am J Pathol 134: 1027-1038, 1989.